- Home
- JAKK vs CRGX Comparison
JAKK vs CRGX Comparison
Compare JAKK & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- CRGX
- Stock Information
- Founded
- JAKK 1995
- CRGX 2021
- Country
- JAKK United States
- CRGX United States
- Employees
- JAKK 680
- CRGX N/A
- Industry
- JAKK Recreational Games/Products/Toys
- CRGX
- Sector
- JAKK Consumer Discretionary
- CRGX
- Exchange
- JAKK Nasdaq
- CRGX Nasdaq
- Market Cap
- JAKK 230.6M
- CRGX 190.0M
- IPO Year
- JAKK 1996
- CRGX 2023
- Fundamental
- Price
- JAKK $20.44
- CRGX $4.27
- Analyst Decision
- JAKK Strong Buy
- CRGX Hold
- Analyst Count
- JAKK 4
- CRGX 7
- Target Price
- JAKK $41.75
- CRGX $4.67
- AVG Volume (30 Days)
- JAKK 146.4K
- CRGX 663.4K
- Earning Date
- JAKK 07-30-2025
- CRGX 08-11-2025
- Dividend Yield
- JAKK 4.90%
- CRGX N/A
- EPS Growth
- JAKK 47.04
- CRGX N/A
- EPS
- JAKK 4.03
- CRGX N/A
- Revenue
- JAKK $714,219,000.00
- CRGX N/A
- Revenue This Year
- JAKK N/A
- CRGX $58.18
- Revenue Next Year
- JAKK $3.90
- CRGX N/A
- P/E Ratio
- JAKK $5.05
- CRGX N/A
- Revenue Growth
- JAKK 2.89
- CRGX N/A
- 52 Week Low
- JAKK $17.06
- CRGX $3.00
- 52 Week High
- JAKK $35.79
- CRGX $25.45
- Technical
- Relative Strength Index (RSI)
- JAKK 49.92
- CRGX 45.02
- Support Level
- JAKK $20.30
- CRGX $4.33
- Resistance Level
- JAKK $23.30
- CRGX $4.48
- Average True Range (ATR)
- JAKK 0.95
- CRGX 0.19
- MACD
- JAKK -0.06
- CRGX -0.02
- Stochastic Oscillator
- JAKK 45.01
- CRGX 21.14
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.